Navigation Links
Warner Chilcott Announces NDA Submission for Low Dose Oral Contraceptive
Date:3/27/2009

vestor communications.

We caution you that the foregoing list of important factors is not exclusive. In addition, in light of these risks and uncertainties, the matters referred to in our forward-looking statements may not occur. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as may be required by law.


'/>"/>
SOURCE Warner Chilcott Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
2. Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2008 Financial Results
3. Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Brothers Movie to Be Filmed About Him
4. Warner Chilcott Reports the Death of Its Director James Andress
5. Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
6. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
7. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
8. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
9. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
10. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
11. Biotechnology Value Fund, L.P. Announces Overwhelming Support to Remove the Board of Directors of Avigen, Inc. at Special Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Global Stem Cells Group.com ... Shenzhen HANK Bioengineering Co., Ltd. and its Chinese-American ... establish a stem cells training course in the ... 2015. , Shenzhen HANK is a biotechnology company ... microbiologist and virologist, to integrate research, development, production, ...
(Date:2/28/2015)... 2015 Increasing its efforts to resolve the ... first three episodes of The GMO TRUTH podcast on both ... as it continues its mission to discover the truth and ... phase, to “uncover the truth about the GMOs in our ... GMO Truth Podcast is an expansion of the documentary/investigative film-making ...
(Date:2/27/2015)... 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... for its newly developed Bruton,s tyrosine kinase (BTK) ... completed. The results of these preclinical evaluations have ... Administration. The feedback received from the Agency is ... study. Additional preclinical work is required to begin ...
(Date:2/27/2015)... February 27, 2015 Immunovaccine Inc. ... immunotherapy company, today announced that the U.S. Food ... Fast Track designation and Phase I clinical trials ... with the mutual co-development agreement signed with Gilead ... Track designation for the DPX-Survivac. , “We have ...
Breaking Biology Technology:Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3The Walk a Mile Project Launches “GMO Truth” Podcast 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3
... Yongye Biotechnology,International, Inc. (OTC Bulletin Board: YGYB; "Yongye" ... of nutrients for plants and,animals, located in the ... management will present at the upcoming Roth 21st ... , The date, time, ...
... today announced the appointment of Babatunde A. Otulana, M.D., ... medical officer.Dr. Otulana, 52, will provide medical as well ... it moves forward with the development of AerovantTM for ... has more than 20 years of experience in pulmonary ...
... Stock Exchange Symbol: LRILAVAL, QC, Feb. 9 /PRNewswire-FirstCall/ - ... "Company"), a Canadian based global non-clinical contract research organization ... Officer of the Company, will be presenting at the ... 11, 2009 at 9.30 am at the Waldorf Astoria ...
Cached Biology Technology:Yongye Biotechnology to Present at Roth Conference 2Yongye Biotechnology to Present at Roth Conference 3Aerovance Appoints Babatunde A. Otulana, M.D., as Chief Medical Officer 2
(Date:2/19/2015)... Feb .19, 2015 Research and Markets ... of the "Military Electro-Optical / Infrared Systems ... by Platform - Forecast to 2020" report ... electro-optical/infrared systems market is expected to reach $16.35 ... 7.71%. This report segments the military ...
(Date:2/13/2015)... TAIPEI , Feb. 13, 2015 ... service company that aims to transform cancer genomic ... announced that the company has raised US$ 8 million ... Based in Taipei, Taiwan ... tests, ACTDrug™, ACTOnco™. With the aim to implement ...
(Date:2/12/2015)... 12, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62/113114 for DISTRIBUTED METHOD AND SYSTEM TO ... patent further establishes NXT-ID,s position in the emerging "Internet ... the ability for multiple devices to collaborate with one ...
Breaking Biology News(10 mins):Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3ACT Genomics Raises $8 Million in its First Private Funding Round 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3
... of the Institute of Tropical Medicine (ITG) discovered a parasite ... but at the same time had become better in withstanding ... in developing a superbug. For it appears the battle against ... "To our knowledge it is the first time such a ...
... The Danish National Advanced Technology Foundation is donating ... brings together Denmark,s leading players within the sustainable use ... Mller Mrsk, Novozymes, Haldor Topse, Man Diesel & Turbo ... for the parties, joint research aimed at developing specific ...
... in recent years that wild chilies develop their trademark pungency, or ... seeds. But that doesn,t explain why some chilies are hot and ... growing in dry areas need more water to produce as many ... a threat in dryer environments so chilies in those areas are ...
Cached Biology News:Do our medicines boost pathogens? 2Do our medicines boost pathogens? 3New research platform paves way for future bio-based society 2To turn up the heat in chilies, just add water 2
See product name for description....
... Custom Production Service - Conjugation ... Conjugation Biotin Conjugation Fluorescein Isothiocyanate ... Conjugation Allophycocyanin Conjugation Alexa Fluor ... Alexa Fluor 405 Conjugation Rpe-Alexa ...
... Design , Customer Peptide Synthesis , 20 Amino Acid ... , 20 mg will return to customer for future usage ... 2 , Maintenance 102 days/each , ... x5 /each , Test bleed (app. 5 ...
Request Info...
Biology Products: